未登录

K

Kangdong Liu

Zhengzhou University

H指数:17

被引数:1,084

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Selection and identification of DNA aptamer binding VDAC1 for tumor tissue imaging and targeted drug delivery

DNA适配体与VDAC1结合的选择与鉴定：用于肿瘤组织成像和靶向药物递送

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2025-05-010

PRE

Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials

IF6.5

2025-02-070

OAAI

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

癌症中的泛素化与去泛素化：从作用机制到新型治疗策略

MOLECULAR CANCER

IF33.9

2024-07-251

OAAI

Selective inhibition of c-Met signaling pathways with a bispecific DNA nanoconnector for the targeted therapy of cancer

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-07-011

PRE

Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets

IF6.1

2024-04-231

OA

Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-02-013

PRE

Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers

癌症/睾丸抗原: 消化道癌症的有希望的免疫治疗靶点

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-168

OAAI

DNA Aptamer Selected against Esophageal Squamous Cell Carcinoma for Tissue Imaging and Targeted Therapy with Integrin?1 as a Molecular

ANALYTICAL CHEMISTRY

IF6.7

2022-12-0210

PRE

Ubiquitination of ADRα1d/SerpinA1 complex stimulates hypoxia to induce gastric tumorigenesis with a combination of Helicobacter pylori and chronic stress through IL-1α

IF5.1

2022-05-072

OA

MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma

IF13.4

2022-04-2918

OAAI

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-01-2855

OAAI

Evolution of DNA aptamers against esophageal squamous cell carcinoma using cell-SELEX

IF3.3

2021-01-0111

PRE

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2020-06-0913

OAAI

Highly sensitive and specific detection of tumor cells based on a split aptamer-triggered dual hybridization chain reaction

IF3.3

2020-01-0119

PREAI

Ornithine decarboxylase inhibition downregulates multiple pathways involved in the formation of precancerous lesions of esophageal squamous cell cancer

MOLECULAR CARCINOGENESIS

IF3.2

2019-12-0313

PREAI

Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma

IF3.9

2019-11-0714

OAAI

Targeting ornithine decarboxylase down-regulates multiple pathways involved in precancerous lesion formation of esophageal squamous cell cancer

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Quercetin-3-methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways

MOLECULAR CARCINOGENESIS

IF3.2

2018-08-2838

PREAI

Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse model

人脐静脉内皮细胞疫苗在人源化小鼠模型中抑制食管鳞状细胞癌的血管生成

ONCOLOGY REPORTS

IF3.9

2018-08-179

OAAI

RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth

CANCER RESEARCH

IF16.6

2018-07-010

PRE